| Name | Walmart Phar 1768 |
|---|---|
| Organization Name | Walmart Inc |
| Location | 1355 Sandhill Rd, Orem, Utah 84058 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (801) 221-0700 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products, today announced that Amgen Inc. has licensed the exclusive right to use the Company's maytansinoid Targeted Antibody Payload (TAP) technology to develop anticancer therapeutics to an undisclosed target found on solid tumors.
ANRS 12286 MOBIDIP, a clinical trial running in parallel in three countries in sub-Saharan Africa (Cameroon, Burkina Faso, and Senegal), shows that dual therapy with lamivudine and a boosted protease inhibitor is effective as second-line treatment in patients infected by HIV with multiple mutations.
The Myelodysplastic Syndromes (MDS) Foundation says a study published this week in the Journal of Clinical Oncology concludes VIDAZA (azacitidine) "prolongs survival and is well tolerated" in patients with acute myeloid leukemia (AML) - an aggressive form of leukemia that in many cases progresses from MDS.
Stem cells, often lauded as future cures for numerous diseases, are immature "master" cells that can be programmed to become many kinds of tissue, but experts have known for a long time that stem cells harvested from embryos can turn cancerous and have been linked to leukaemias and breast cancer.
Research presented by P&G Beauty & Grooming scientists at the 68th Annual Meeting of the American Academy of Dermatology (Miami Beach, FL, March 5-9) examines skin care science from multiple perspectives, offering insights into how ingredient formulations, care regimens and gene expressions impact skin condition.
› Verified 7 days ago
| NPI Number | 1952328148 |
| Organization Name | WALMART INC. |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1355 Sandhill Rd, Orem, UT 84058 |
| Phone Number | 801-221-0700 |
News Archive
ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products, today announced that Amgen Inc. has licensed the exclusive right to use the Company's maytansinoid Targeted Antibody Payload (TAP) technology to develop anticancer therapeutics to an undisclosed target found on solid tumors.
ANRS 12286 MOBIDIP, a clinical trial running in parallel in three countries in sub-Saharan Africa (Cameroon, Burkina Faso, and Senegal), shows that dual therapy with lamivudine and a boosted protease inhibitor is effective as second-line treatment in patients infected by HIV with multiple mutations.
The Myelodysplastic Syndromes (MDS) Foundation says a study published this week in the Journal of Clinical Oncology concludes VIDAZA (azacitidine) "prolongs survival and is well tolerated" in patients with acute myeloid leukemia (AML) - an aggressive form of leukemia that in many cases progresses from MDS.
Stem cells, often lauded as future cures for numerous diseases, are immature "master" cells that can be programmed to become many kinds of tissue, but experts have known for a long time that stem cells harvested from embryos can turn cancerous and have been linked to leukaemias and breast cancer.
Research presented by P&G Beauty & Grooming scientists at the 68th Annual Meeting of the American Academy of Dermatology (Miami Beach, FL, March 5-9) examines skin care science from multiple perspectives, offering insights into how ingredient formulations, care regimens and gene expressions impact skin condition.
› Verified 7 days ago
News Archive
ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products, today announced that Amgen Inc. has licensed the exclusive right to use the Company's maytansinoid Targeted Antibody Payload (TAP) technology to develop anticancer therapeutics to an undisclosed target found on solid tumors.
ANRS 12286 MOBIDIP, a clinical trial running in parallel in three countries in sub-Saharan Africa (Cameroon, Burkina Faso, and Senegal), shows that dual therapy with lamivudine and a boosted protease inhibitor is effective as second-line treatment in patients infected by HIV with multiple mutations.
The Myelodysplastic Syndromes (MDS) Foundation says a study published this week in the Journal of Clinical Oncology concludes VIDAZA (azacitidine) "prolongs survival and is well tolerated" in patients with acute myeloid leukemia (AML) - an aggressive form of leukemia that in many cases progresses from MDS.
Stem cells, often lauded as future cures for numerous diseases, are immature "master" cells that can be programmed to become many kinds of tissue, but experts have known for a long time that stem cells harvested from embryos can turn cancerous and have been linked to leukaemias and breast cancer.
Research presented by P&G Beauty & Grooming scientists at the 68th Annual Meeting of the American Academy of Dermatology (Miami Beach, FL, March 5-9) examines skin care science from multiple perspectives, offering insights into how ingredient formulations, care regimens and gene expressions impact skin condition.
› Verified 7 days ago
Petersen Medical Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1268 S 1380 W, Orem, Utah 84058 Phone: (801) 374-8101 | |
Hanger Clinc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1415 S State St, Orem, Utah 84097 Phone: (801) 356-1830 | |
Harmons Pharmacy 88 Type: Community/Retail Pharmacy Location: 870 E 800 N, Orem, Utah 84097 Phone: (801) 714-4150 | |
Lincare Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1442 W Business Park Dr, Orem, Utah 84058 Phone: (801) 224-3338 | |
Lenscrafters #9560 Type: Eyewear Supplier (Equipment, not the service) Location: 575 E University Pkwy, Orem, Utah 84097 Phone: (801) 788-3832 |